Investing.com - Ginkgo Bioworks reported on Monday third quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Ginkgo Bioworks announced earnings per share of $-0.410 on revenue of $66.4M. Analysts polled by Investing.com anticipated EPS of $-0.290 on revenue of $60.35M.
Ginkgo Bioworks shares are down 81% from the beginning of the year and are trading at $2.550 , down-from-52-week-high.
Ginkgo Bioworks shares lost 4.85% in after-hours trade the report.
Ginkgo Bioworks follows other major Materials sector earnings this month
Ginkgo Bioworks's report follows an earnings missed by Air Liquide ADR on Tuesday, October 25, 2022, who reported EPS of $0.5852 on revenue of $8.21B, compared to forecasts EPS of $0.5954 on revenue of $7.46B.
Vale ADR had beat expectations on Thursday, October 27, 2022 with third quarter EPS of $0.98 on revenue of $9.93B, compared to forecast for EPS of $0.5594 on revenue of $10.15B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar